Back to Journals » Therapeutics and Clinical Risk Management » Volume 13

Alemtuzumab: a review of efficacy and risks in the treatment of relapsing remitting multiple sclerosis

Total article views   Abstract views HTML views PDF downloads Totals
9,811 Dovepress* 4,865 1,856+ 1,010 6,721
PubMed Central* 0 3,090 644 3,090
Totals 4,865 4,946 1,654 9,811
*Since 14 July 2017
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
12 1 0 0 4 7

View citations on PubMed Central and Google Scholar